Compile Data Set for Download or QSAR

Found 371 hits with Last Name = 'reichart' and Initial = 'f'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530090 (CHEMBL4443665) Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCCCNC(=O)CCCCCNC(=O)CCc2ccc3C=C4C(C)=CC(C)=[N+]4[B-](F)(F)n23)N(C)C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r,c:37,40,t:34| Show InChI InChI=1S/C58H90BF2N15O12/c1-34(2)27-41-53(84)71-40(15-13-25-66-58(62)63)52(83)67-32-49(79)70-42(31-51(81)82)54(85)72-43(28-35(3)4)56(87)74-26-14-17-45(74)57(88)73(7)44(55(86)68-33-50(80)69-41)16-10-12-24-64-47(77)18-9-8-11-23-65-48(78)22-21-38-19-20-39-30-46-36(5)29-37(6)75(46)59(60,61)76(38)39/h19-20,29-30,34-35,40-45H,8-18,21-28,31-33H2,1-7H3,(H,64,77)(H,65,78)(H,67,83)(H,68,86)(H,69,80)(H,70,79)(H,71,84)(H,72,85)(H,81,82)(H4,62,63,66)/t40-,41-,42-,43-,44-,45+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	0.0600	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530090 (CHEMBL4443665) Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCCCNC(=O)CCCCCNC(=O)CCc2ccc3C=C4C(C)=CC(C)=[N+]4[B-](F)(F)n23)N(C)C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r,c:37,40,t:34| Show InChI InChI=1S/C58H90BF2N15O12/c1-34(2)27-41-53(84)71-40(15-13-25-66-58(62)63)52(83)67-32-49(79)70-42(31-51(81)82)54(85)72-43(28-35(3)4)56(87)74-26-14-17-45(74)57(88)73(7)44(55(86)68-33-50(80)69-41)16-10-12-24-64-47(77)18-9-8-11-23-65-48(78)22-21-38-19-20-39-30-46-36(5)29-37(6)75(46)59(60,61)76(38)39/h19-20,29-30,34-35,40-45H,8-18,21-28,31-33H2,1-7H3,(H,64,77)(H,65,78)(H,67,83)(H,68,86)(H,69,80)(H,70,79)(H,71,84)(H,72,85)(H,81,82)(H4,62,63,66)/t40-,41-,42-,43-,44-,45+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	0.0600	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287688 (CHEMBL4173382) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)Nc1ccccc1 |r| Show InChI InChI=1S/C20H22N6O5/c21-20(22)25-14-8-4-5-12(9-14)18(30)23-11-16(27)26-15(10-17(28)29)19(31)24-13-6-2-1-3-7-13/h1-9,15H,10-11H2,(H,23,30)(H,24,31)(H,26,27)(H,28,29)(H4,21,22,25)/t15-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.210	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-6 (Homo sapiens (Human))	BDBM50530099 (CHEMBL4441624) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)N(C)C(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC1=O |r| Show InChI InChI=1S/C51H75N13O11/c1-30(2)25-35-45(70)57-31(3)43(68)62-38(27-33-17-9-6-10-18-33)49(74)64-24-14-21-40(64)50(75)63(4)39(20-11-12-22-52)48(73)61-36(26-32-15-7-5-8-16-32)46(71)59-34(19-13-23-55-51(53)54)44(69)56-29-41(65)58-37(28-42(66)67)47(72)60-35/h5-10,15-18,30-31,34-40H,11-14,19-29,52H2,1-4H3,(H,56,69)(H,57,70)(H,58,65)(H,59,71)(H,60,72)(H,61,73)(H,62,68)(H,66,67)(H4,53,54,55)/t31-,34-,35-,36-,37-,38-,39-,40+/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	0.260	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-6 (Homo sapiens (Human))	BDBM50530099 (CHEMBL4441624) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)N(C)C(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC1=O |r| Show InChI InChI=1S/C51H75N13O11/c1-30(2)25-35-45(70)57-31(3)43(68)62-38(27-33-17-9-6-10-18-33)49(74)64-24-14-21-40(64)50(75)63(4)39(20-11-12-22-52)48(73)61-36(26-32-15-7-5-8-16-32)46(71)59-34(19-13-23-55-51(53)54)44(69)56-29-41(65)58-37(28-42(66)67)47(72)60-35/h5-10,15-18,30-31,34-40H,11-14,19-29,52H2,1-4H3,(H,56,69)(H,57,70)(H,58,65)(H,59,71)(H,60,72)(H,61,73)(H,62,68)(H,66,67)(H4,53,54,55)/t31-,34-,35-,36-,37-,38-,39-,40+/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	0.260	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50235980 (2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-...) Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7](-[#6])-[#6](=O)-[#6@@H](-[#6]-c2ccccc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6]-1=O |r| Show InChI InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MMDB PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.540	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50235980 (2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-...) Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7](-[#6])-[#6](=O)-[#6@@H](-[#6]-c2ccccc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6]-1=O |r| Show InChI InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MMDB PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.540	n/a	n/a	n/a	n/a	n/a	n/a
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL) Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...				Bioorg Med Chem Lett 30: (2020) Article DOI: 10.1016/j.bmcl.2020.127039 BindingDB Entry DOI: 10.7270/Q2RJ4P16
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-6 (Homo sapiens (Human))	BDBM50530110 (CHEMBL4575627) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC1=O |r| Show InChI InChI=1S/C43H64N12O11/c1-23(2)19-28-38(62)48-24(3)36(60)53-30(20-26-11-6-5-7-12-26)41(65)55-18-10-15-32(55)42(66)54-17-9-14-31(54)40(64)49-25(4)35(59)51-27(13-8-16-46-43(44)45)37(61)47-22-33(56)50-29(21-34(57)58)39(63)52-28/h5-7,11-12,23-25,27-32H,8-10,13-22H2,1-4H3,(H,47,61)(H,48,62)(H,49,64)(H,50,56)(H,51,59)(H,52,63)(H,53,60)(H,57,58)(H4,44,45,46)/t24-,25-,27-,28-,29-,30-,31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	0.670	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-6 (Homo sapiens (Human))	BDBM50530110 (CHEMBL4575627) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC1=O |r| Show InChI InChI=1S/C43H64N12O11/c1-23(2)19-28-38(62)48-24(3)36(60)53-30(20-26-11-6-5-7-12-26)41(65)55-18-10-15-32(55)42(66)54-17-9-14-31(54)40(64)49-25(4)35(59)51-27(13-8-16-46-43(44)45)37(61)47-22-33(56)50-29(21-34(57)58)39(63)52-28/h5-7,11-12,23-25,27-32H,8-10,13-22H2,1-4H3,(H,47,61)(H,48,62)(H,49,64)(H,50,56)(H,51,59)(H,52,63)(H,53,60)(H,57,58)(H4,44,45,46)/t24-,25-,27-,28-,29-,30-,31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	0.670	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287724 (CHEMBL4163249) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCc1ccccc1 |r| Show InChI InChI=1S/C21H24N6O5/c22-21(23)26-15-8-4-7-14(9-15)19(31)25-12-17(28)27-16(10-18(29)30)20(32)24-11-13-5-2-1-3-6-13/h1-9,16H,10-12H2,(H,24,32)(H,25,31)(H,27,28)(H,29,30)(H4,22,23,26)/t16-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.790	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287989 (CHEMBL4173588) Show SMILES C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)c1cccc(NC(N)=N)c1)c1ccccc1 |r| Show InChI InChI=1S/C22H26N6O5/c1-13(14-6-3-2-4-7-14)26-21(33)17(11-19(30)31)28-18(29)12-25-20(32)15-8-5-9-16(10-15)27-22(23)24/h2-10,13,17H,11-12H2,1H3,(H,25,32)(H,26,33)(H,28,29)(H,30,31)(H4,23,24,27)/t13-,17-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.910	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287726 (CHEMBL4177354) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCC(c1ccccc1)c1ccccc1 |r| Show InChI InChI=1S/C28H30N6O5/c29-28(30)33-21-13-7-12-20(14-21)26(38)32-17-24(35)34-23(15-25(36)37)27(39)31-16-22(18-8-3-1-4-9-18)19-10-5-2-6-11-19/h1-14,22-23H,15-17H2,(H,31,39)(H,32,38)(H,34,35)(H,36,37)(H4,29,30,33)/t23-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.910	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50004058 ((2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-yl...) Show SMILES CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O Show InChI InChI=1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	Purchase DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars	DrugBank PDB Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL) Curated by ChEMBL					Assay Description Inhibition of fibrinogen binding to human platelet integrin alpha2b beta3 by ELISA based solid phase binding assay				Bioorg Med Chem Lett 30: (2020) Article DOI: 10.1016/j.bmcl.2020.127039 BindingDB Entry DOI: 10.7270/Q2RJ4P16
					More data for this Ligand-Target Pair				3D Structure (crystal)
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287687 (CHEMBL4163281) Show SMILES COc1ccc(CNC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)c2cccc(NC(N)=N)c2)cc1 |r| Show InChI InChI=1S/C22H26N6O6/c1-34-16-7-5-13(6-8-16)11-25-21(33)17(10-19(30)31)28-18(29)12-26-20(32)14-3-2-4-15(9-14)27-22(23)24/h2-9,17H,10-12H2,1H3,(H,25,33)(H,26,32)(H,28,29)(H,30,31)(H4,23,24,27)/t17-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287917 (CHEMBL4166720) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCc1cccc(c1)-c1ccccc1 |r| Show InChI InChI=1S/C27H28N6O5/c28-27(29)32-21-11-5-10-20(13-21)25(37)31-16-23(34)33-22(14-24(35)36)26(38)30-15-17-6-4-9-19(12-17)18-7-2-1-3-8-18/h1-13,22H,14-16H2,(H,30,38)(H,31,37)(H,33,34)(H,35,36)(H4,28,29,32)/t22-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530119 (CHEMBL4449438) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C37H61N11O10/c1-19(2)15-23-32(54)44-22(9-6-12-40-37(38)39)31(53)41-18-28(49)43-24(17-29(50)51)33(55)46-25(16-20(3)4)35(57)48-14-8-11-27(48)36(58)47-13-7-10-26(47)34(56)42-21(5)30(52)45-23/h19-27H,6-18H2,1-5H3,(H,41,53)(H,42,56)(H,43,49)(H,44,54)(H,45,52)(H,46,55)(H,50,51)(H4,38,39,40)/t21-,22-,23-,24-,25-,26-,27+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530119 (CHEMBL4449438) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C37H61N11O10/c1-19(2)15-23-32(54)44-22(9-6-12-40-37(38)39)31(53)41-18-28(49)43-24(17-29(50)51)33(55)46-25(16-20(3)4)35(57)48-14-8-11-27(48)36(58)47-13-7-10-26(47)34(56)42-21(5)30(52)45-23/h19-27H,6-18H2,1-5H3,(H,41,53)(H,42,56)(H,43,49)(H,44,54)(H,45,52)(H,46,55)(H,50,51)(H4,38,39,40)/t21-,22-,23-,24-,25-,26-,27+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287706 (CHEMBL4173995) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCc1ccc(Cl)cc1 |r| Show InChI InChI=1S/C21H23ClN6O5/c22-14-6-4-12(5-7-14)10-25-20(33)16(9-18(30)31)28-17(29)11-26-19(32)13-2-1-3-15(8-13)27-21(23)24/h1-8,16H,9-11H2,(H,25,33)(H,26,32)(H,28,29)(H,30,31)(H4,23,24,27)/t16-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287705 (CHEMBL4169540) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NC(c1ccccc1)c1ccccc1 |r| Show InChI InChI=1S/C27H28N6O5/c28-27(29)31-20-13-7-12-19(14-20)25(37)30-16-22(34)32-21(15-23(35)36)26(38)33-24(17-8-3-1-4-9-17)18-10-5-2-6-11-18/h1-14,21,24H,15-16H2,(H,30,37)(H,32,34)(H,33,38)(H,35,36)(H4,28,29,31)/t21-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530088 (CHEMBL4520646) Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C37H61N11O10/c1-6-20(4)29-34(56)44-22(10-7-13-40-37(38)39)31(53)41-18-27(49)43-23(17-28(50)51)32(54)45-24(16-19(2)3)35(57)48-15-9-12-26(48)36(58)47-14-8-11-25(47)33(55)42-21(5)30(52)46-29/h19-26,29H,6-18H2,1-5H3,(H,41,53)(H,42,55)(H,43,49)(H,44,56)(H,45,54)(H,46,52)(H,50,51)(H4,38,39,40)/t20-,21-,22-,23-,24-,25-,26+,29-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.5	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530088 (CHEMBL4520646) Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C37H61N11O10/c1-6-20(4)29-34(56)44-22(10-7-13-40-37(38)39)31(53)41-18-27(49)43-23(17-28(50)51)32(54)45-24(16-19(2)3)35(57)48-15-9-12-26(48)36(58)47-14-8-11-25(47)33(55)42-21(5)30(52)46-29/h19-26,29H,6-18H2,1-5H3,(H,41,53)(H,42,55)(H,43,49)(H,44,56)(H,45,54)(H,46,52)(H,50,51)(H4,38,39,40)/t20-,21-,22-,23-,24-,25-,26+,29-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.5	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287990 (CHEMBL4165669) Show SMILES C[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)c1cccc(NC(N)=N)c1)c1ccccc1 |r| Show InChI InChI=1S/C22H26N6O5/c1-13(14-6-3-2-4-7-14)26-21(33)17(11-19(30)31)28-18(29)12-25-20(32)15-8-5-9-16(10-15)27-22(23)24/h2-10,13,17H,11-12H2,1H3,(H,25,32)(H,26,33)(H,28,29)(H,30,31)(H4,23,24,27)/t13-,17+/m1/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.60	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287988 (CHEMBL4167167) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCc1ccc(cc1)-c1ccccc1 |r| Show InChI InChI=1S/C27H28N6O5/c28-27(29)32-21-8-4-7-20(13-21)25(37)31-16-23(34)33-22(14-24(35)36)26(38)30-15-17-9-11-19(12-10-17)18-5-2-1-3-6-18/h1-13,22H,14-16H2,(H,30,38)(H,31,37)(H,33,34)(H,35,36)(H4,28,29,32)/t22-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530098 (CHEMBL4584228) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C40H59N11O10/c1-22(2)18-28-38(60)51-17-9-14-30(51)39(61)50-16-8-13-29(50)37(59)45-23(3)33(55)48-26(19-24-10-5-4-6-11-24)35(57)47-25(12-7-15-43-40(41)42)34(56)44-21-31(52)46-27(20-32(53)54)36(58)49-28/h4-6,10-11,22-23,25-30H,7-9,12-21H2,1-3H3,(H,44,56)(H,45,59)(H,46,52)(H,47,57)(H,48,55)(H,49,58)(H,53,54)(H4,41,42,43)/t23-,25-,26-,27-,28-,29-,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.80	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530098 (CHEMBL4584228) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C40H59N11O10/c1-22(2)18-28-38(60)51-17-9-14-30(51)39(61)50-16-8-13-29(50)37(59)45-23(3)33(55)48-26(19-24-10-5-4-6-11-24)35(57)47-25(12-7-15-43-40(41)42)34(56)44-21-31(52)46-27(20-32(53)54)36(58)49-28/h4-6,10-11,22-23,25-30H,7-9,12-21H2,1-3H3,(H,44,56)(H,45,59)(H,46,52)(H,47,57)(H,48,55)(H,49,58)(H,53,54)(H4,41,42,43)/t23-,25-,26-,27-,28-,29-,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.80	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287896 (CHEMBL4170132) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCCc1ccc2ccccc2c1 |r| Show InChI InChI=1S/C26H28N6O5/c27-26(28)31-20-7-3-6-19(13-20)24(36)30-15-22(33)32-21(14-23(34)35)25(37)29-11-10-16-8-9-17-4-1-2-5-18(17)12-16/h1-9,12-13,21H,10-11,14-15H2,(H,29,37)(H,30,36)(H,32,33)(H,34,35)(H4,27,28,31)/t21-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.20	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287986 (CHEMBL4164619) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCCc1ccccc1 |r| Show InChI InChI=1S/C22H26N6O5/c23-22(24)27-16-8-4-7-15(11-16)20(32)26-13-18(29)28-17(12-19(30)31)21(33)25-10-9-14-5-2-1-3-6-14/h1-8,11,17H,9-10,12-13H2,(H,25,33)(H,26,32)(H,28,29)(H,30,31)(H4,23,24,27)/t17-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	2.80	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50545184 (CHEMBL4642869) Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O |r| Show InChI InChI=1S/C28H40N8O7.C2HF3O2/c29-27(30)31-13-7-10-18-23(40)32-16-21(37)33-20(15-22(38)39)24(41)34-19(14-17-8-3-1-4-9-17)25(42)36-28(26(43)35-18)11-5-2-6-12-28;3-2(4,5)1(6)7/h1,3-4,8-9,18-20H,2,5-7,10-16H2,(H,32,40)(H,33,37)(H,34,41)(H,35,43)(H,36,42)(H,38,39)(H4,29,30,31);(H,6,7)/t18-,19+,20-;/m0./s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	3.30	n/a	n/a	n/a	n/a	n/a	n/a
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL) Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...				Bioorg Med Chem Lett 30: (2020) Article DOI: 10.1016/j.bmcl.2020.127039 BindingDB Entry DOI: 10.7270/Q2RJ4P16
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530140 (CHEMBL4445931) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C42H60N12O10/c1-22(2)17-30-40(63)54-16-8-13-32(54)41(64)53-15-7-12-31(53)39(62)48-23(3)35(58)51-28(18-24-20-46-26-10-5-4-9-25(24)26)37(60)50-27(11-6-14-45-42(43)44)36(59)47-21-33(55)49-29(19-34(56)57)38(61)52-30/h4-5,9-10,20,22-23,27-32,46H,6-8,11-19,21H2,1-3H3,(H,47,59)(H,48,62)(H,49,55)(H,50,60)(H,51,58)(H,52,61)(H,56,57)(H4,43,44,45)/t23-,27-,28-,29-,30-,31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	3.70	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530140 (CHEMBL4445931) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C42H60N12O10/c1-22(2)17-30-40(63)54-16-8-13-32(54)41(64)53-15-7-12-31(53)39(62)48-23(3)35(58)51-28(18-24-20-46-26-10-5-4-9-25(24)26)37(60)50-27(11-6-14-45-42(43)44)36(59)47-21-33(55)49-29(19-34(56)57)38(61)52-30/h4-5,9-10,20,22-23,27-32,46H,6-8,11-19,21H2,1-3H3,(H,47,59)(H,48,62)(H,49,55)(H,50,60)(H,51,58)(H,52,61)(H,56,57)(H4,43,44,45)/t23-,27-,28-,29-,30-,31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	3.70	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287987 (CHEMBL4167230) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCCc1c[nH]c2ccccc12 |r| Show InChI InChI=1S/C24H27N7O5/c25-24(26)30-16-5-3-4-14(10-16)22(35)29-13-20(32)31-19(11-21(33)34)23(36)27-9-8-15-12-28-18-7-2-1-6-17(15)18/h1-7,10,12,19,28H,8-9,11,13H2,(H,27,36)(H,29,35)(H,31,32)(H,33,34)(H4,25,26,30)/t19-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530125 (CHEMBL4541418) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O)[C@@H](C)O |r| Show InChI InChI=1S/C42H63N11O11/c1-22(2)19-29-40(63)53-18-10-15-31(53)41(64)52-17-9-14-30(52)38(61)46-23(3)34(57)48-27(20-25-11-6-5-7-12-25)36(59)47-26(13-8-16-45-42(43)44)35(58)51-33(24(4)54)39(62)49-28(21-32(55)56)37(60)50-29/h5-7,11-12,22-24,26-31,33,54H,8-10,13-21H2,1-4H3,(H,46,61)(H,47,59)(H,48,57)(H,49,62)(H,50,60)(H,51,58)(H,55,56)(H4,43,44,45)/t23-,24+,26-,27-,28-,29-,30-,31+,33-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	4.30	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530125 (CHEMBL4541418) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O)[C@@H](C)O |r| Show InChI InChI=1S/C42H63N11O11/c1-22(2)19-29-40(63)53-18-10-15-31(53)41(64)52-17-9-14-30(52)38(61)46-23(3)34(57)48-27(20-25-11-6-5-7-12-25)36(59)47-26(13-8-16-45-42(43)44)35(58)51-33(24(4)54)39(62)49-28(21-32(55)56)37(60)50-29/h5-7,11-12,22-24,26-31,33,54H,8-10,13-21H2,1-4H3,(H,46,61)(H,47,59)(H,48,57)(H,49,62)(H,50,60)(H,51,58)(H,55,56)(H4,43,44,45)/t23-,24+,26-,27-,28-,29-,30-,31+,33-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	4.30	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530103 (CHEMBL4546687) Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C36H59N11O10/c1-19(2)14-22-31(53)44-21(8-5-11-39-36(37)38)30(52)40-17-27(48)43-23(16-29(50)51)32(54)45-24(15-20(3)4)34(56)47-13-7-10-26(47)35(57)46-12-6-9-25(46)33(55)41-18-28(49)42-22/h19-26H,5-18H2,1-4H3,(H,40,52)(H,41,55)(H,42,49)(H,43,48)(H,44,53)(H,45,54)(H,50,51)(H4,37,38,39)/t21-,22-,23-,24-,25-,26+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	4.5	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530103 (CHEMBL4546687) Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C36H59N11O10/c1-19(2)14-22-31(53)44-21(8-5-11-39-36(37)38)30(52)40-17-27(48)43-23(16-29(50)51)32(54)45-24(15-20(3)4)34(56)47-13-7-10-26(47)35(57)46-12-6-9-25(46)33(55)41-18-28(49)42-22/h19-26H,5-18H2,1-4H3,(H,40,52)(H,41,55)(H,42,49)(H,43,48)(H,44,53)(H,45,54)(H,50,51)(H4,37,38,39)/t21-,22-,23-,24-,25-,26+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	4.5	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50287725 (CHEMBL4162220) Show SMILES NC(=N)Nc1cccc(c1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)Nc1cccc2ccccc12 |r| Show InChI InChI=1S/C24H24N6O5/c25-24(26)28-16-8-3-7-15(11-16)22(34)27-13-20(31)29-19(12-21(32)33)23(35)30-18-10-4-6-14-5-1-2-9-17(14)18/h1-11,19H,12-13H2,(H,27,34)(H,29,31)(H,30,35)(H,32,33)(H4,25,26,28)/t19-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4.5	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ degli Studi di Napoli "Federico II" Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISA				J Med Chem 61: 4791-4809 (2018) Article DOI: 10.1021/acs.jmedchem.8b00004 BindingDB Entry DOI: 10.7270/Q22J6FCB
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50545181 (CHEMBL4633117) Show SMILES OC(=O)C(F)(F)F.CC1(C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C25H36N8O7.C2HF3O2/c1-25(2)23(40)32-15(9-6-10-28-24(26)27)20(37)29-13-18(34)30-17(12-19(35)36)21(38)31-16(22(39)33-25)11-14-7-4-3-5-8-14;3-2(4,5)1(6)7/h3-5,7-8,15-17H,6,9-13H2,1-2H3,(H,29,37)(H,30,34)(H,31,38)(H,32,40)(H,33,39)(H,35,36)(H4,26,27,28);(H,6,7)/t15-,16+,17-;/m0./s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	5.5	n/a	n/a	n/a	n/a	n/a	n/a
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL) Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...				Bioorg Med Chem Lett 30: (2020) Article DOI: 10.1016/j.bmcl.2020.127039 BindingDB Entry DOI: 10.7270/Q2RJ4P16
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530124 (CHEMBL4537950) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C41H61N11O11/c1-22(2)18-28-39(62)52-17-9-14-31(52)40(63)51-16-8-13-30(51)38(61)45-23(3)33(56)47-26(19-24-10-5-4-6-11-24)35(58)46-25(12-7-15-44-41(42)43)34(57)50-29(21-53)37(60)48-27(20-32(54)55)36(59)49-28/h4-6,10-11,22-23,25-31,53H,7-9,12-21H2,1-3H3,(H,45,61)(H,46,58)(H,47,56)(H,48,60)(H,49,59)(H,50,57)(H,54,55)(H4,42,43,44)/t23-,25-,26-,27-,28-,29-,30-,31+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	5.80	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530124 (CHEMBL4537950) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C41H61N11O11/c1-22(2)18-28-39(62)52-17-9-14-31(52)40(63)51-16-8-13-30(51)38(61)45-23(3)33(56)47-26(19-24-10-5-4-6-11-24)35(58)46-25(12-7-15-44-41(42)43)34(57)50-29(21-53)37(60)48-27(20-32(54)55)36(59)49-28/h4-6,10-11,22-23,25-31,53H,7-9,12-21H2,1-3H3,(H,45,61)(H,46,58)(H,47,56)(H,48,60)(H,49,59)(H,50,57)(H,54,55)(H4,42,43,44)/t23-,25-,26-,27-,28-,29-,30-,31+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	5.80	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530122 (CHEMBL4577219) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C35H55N11O12/c1-17(2)13-22-33(57)46-12-6-9-24(46)34(58)45-11-5-8-23(45)32(56)40-18(3)28(52)43-21(15-27(50)51)31(55)42-19(7-4-10-38-35(36)37)29(53)39-16-25(47)41-20(14-26(48)49)30(54)44-22/h17-24H,4-16H2,1-3H3,(H,39,53)(H,40,56)(H,41,47)(H,42,55)(H,43,52)(H,44,54)(H,48,49)(H,50,51)(H4,36,37,38)/t18-,19-,20-,21-,22-,23-,24+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	6.30	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530122 (CHEMBL4577219) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C35H55N11O12/c1-17(2)13-22-33(57)46-12-6-9-24(46)34(58)45-11-5-8-23(45)32(56)40-18(3)28(52)43-21(15-27(50)51)31(55)42-19(7-4-10-38-35(36)37)29(53)39-16-25(47)41-20(14-26(48)49)30(54)44-22/h17-24H,4-16H2,1-3H3,(H,39,53)(H,40,56)(H,41,47)(H,42,55)(H,43,52)(H,44,54)(H,48,49)(H,50,51)(H4,36,37,38)/t18-,19-,20-,21-,22-,23-,24+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	6.30	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530120 (CHEMBL4455010) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O)c1ccccc1 |r| Show InChI InChI=1S/C39H57N11O10/c1-21(2)18-26-37(59)50-17-9-14-28(50)38(60)49-16-8-13-27(49)35(57)44-22(3)32(54)48-31(23-10-5-4-6-11-23)36(58)46-24(12-7-15-42-39(40)41)33(55)43-20-29(51)45-25(19-30(52)53)34(56)47-26/h4-6,10-11,21-22,24-28,31H,7-9,12-20H2,1-3H3,(H,43,55)(H,44,57)(H,45,51)(H,46,58)(H,47,56)(H,48,54)(H,52,53)(H4,40,41,42)/t22-,24-,25-,26-,27-,28+,31-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	6.40	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530120 (CHEMBL4455010) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O)c1ccccc1 |r| Show InChI InChI=1S/C39H57N11O10/c1-21(2)18-26-37(59)50-17-9-14-28(50)38(60)49-16-8-13-27(49)35(57)44-22(3)32(54)48-31(23-10-5-4-6-11-23)36(58)46-24(12-7-15-42-39(40)41)33(55)43-20-29(51)45-25(19-30(52)53)34(56)47-26/h4-6,10-11,21-22,24-28,31H,7-9,12-20H2,1-3H3,(H,43,55)(H,44,57)(H,45,51)(H,46,58)(H,47,56)(H,48,54)(H,52,53)(H4,40,41,42)/t22-,24-,25-,26-,27-,28+,31-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	6.40	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530121 (CHEMBL4437241) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C37H62N12O10/c1-20(2)17-25-35(58)49-16-8-12-27(49)36(59)48-15-7-11-26(48)34(57)43-21(3)30(53)45-23(9-4-5-13-38)32(55)46-22(10-6-14-41-37(39)40)31(54)42-19-28(50)44-24(18-29(51)52)33(56)47-25/h20-27H,4-19,38H2,1-3H3,(H,42,54)(H,43,57)(H,44,50)(H,45,53)(H,46,55)(H,47,56)(H,51,52)(H4,39,40,41)/t21-,22-,23-,24-,25-,26-,27+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	7.30	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530121 (CHEMBL4437241) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C37H62N12O10/c1-20(2)17-25-35(58)49-16-8-12-27(49)36(59)48-15-7-11-26(48)34(57)43-21(3)30(53)45-23(9-4-5-13-38)32(55)46-22(10-6-14-41-37(39)40)31(54)42-19-28(50)44-24(18-29(51)52)33(56)47-25/h20-27H,4-19,38H2,1-3H3,(H,42,54)(H,43,57)(H,44,50)(H,45,53)(H,46,55)(H,47,56)(H,51,52)(H4,39,40,41)/t21-,22-,23-,24-,25-,26-,27+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	7.30	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530086 (CHEMBL4470642) Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCCCNC(C)=O)N(C)C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C40H68N12O11/c1-22(2)17-26-35(59)49-25(11-9-15-44-40(41)42)34(58)45-20-31(54)48-27(19-33(56)57)36(60)50-28(18-23(3)4)38(62)52-16-10-13-30(52)39(63)51(6)29(12-7-8-14-43-24(5)53)37(61)46-21-32(55)47-26/h22-23,25-30H,7-21H2,1-6H3,(H,43,53)(H,45,58)(H,46,61)(H,47,55)(H,48,54)(H,49,59)(H,50,60)(H,56,57)(H4,41,42,44)/t25-,26-,27-,28-,29-,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530086 (CHEMBL4470642) Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCCCNC(C)=O)N(C)C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O |r| Show InChI InChI=1S/C40H68N12O11/c1-22(2)17-26-35(59)49-25(11-9-15-44-40(41)42)34(58)45-20-31(54)48-27(19-33(56)57)36(60)50-28(18-23(3)4)38(62)52-16-10-13-30(52)39(63)51(6)29(12-7-8-14-43-24(5)53)37(61)46-21-32(55)47-26/h22-23,25-30H,7-21H2,1-6H3,(H,43,53)(H,45,58)(H,46,61)(H,47,55)(H,48,54)(H,49,59)(H,50,60)(H,56,57)(H4,41,42,44)/t25-,26-,27-,28-,29-,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-5 (Homo sapiens (Human))	BDBM50235980 (2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-...) Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7](-[#6])-[#6](=O)-[#6@@H](-[#6]-c2ccccc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6]-1=O |r| Show InChI InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MMDB PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL) Curated by ChEMBL					Assay Description Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta5 (Gly24 to Asn719 residues) expressed in CHO c...				Bioorg Med Chem Lett 30: (2020) Article DOI: 10.1016/j.bmcl.2020.127039 BindingDB Entry DOI: 10.7270/Q2RJ4P16
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530142 (CHEMBL4456161) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C34H55N11O10/c1-17(2)14-22-32(54)45-13-7-10-24(45)33(55)44-12-6-9-23(44)31(53)40-18(3)27(49)39-19(4)28(50)42-20(8-5-11-37-34(35)36)29(51)38-16-25(46)41-21(15-26(47)48)30(52)43-22/h17-24H,5-16H2,1-4H3,(H,38,51)(H,39,49)(H,40,53)(H,41,46)(H,42,50)(H,43,52)(H,47,48)(H4,35,36,37)/t18-,19-,20-,21-,22-,23-,24+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	8.10	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-8 (Homo sapiens (Human))	BDBM50530142 (CHEMBL4456161) Show SMILES CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O |r| Show InChI InChI=1S/C34H55N11O10/c1-17(2)14-22-32(54)45-13-7-10-24(45)33(55)44-12-6-9-23(44)31(53)40-18(3)27(49)39-19(4)28(50)42-20(8-5-11-37-34(35)36)29(51)38-16-25(46)41-21(15-26(47)48)30(52)43-22/h17-24H,5-16H2,1-4H3,(H,38,51)(H,39,49)(H,40,53)(H,41,46)(H,42,50)(H,43,52)(H,47,48)(H4,35,36,37)/t18-,19-,20-,21-,22-,23-,24+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	8.10	n/a	n/a	n/a	n/a	n/a	n/a
Technische Universit£t M£nchen Curated by ChEMBL					Assay Description Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay				J Med Chem 62: 2024-2037 (2019) Article DOI: 10.1021/acs.jmedchem.8b01588 BindingDB Entry DOI: 10.7270/Q26T0R53
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 371 total )  |  Next  |  Last  >>

Jump to: